![Carol Schafer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Schafer
Directeur/Membre du Conseil chez
INSMED INCORPORATED
Fortune : 7 M $ au 31/05/2026
Profil
Carol Anne Schafer is currently an Independent Director at Insmed, Inc. since 2020, Immunome, Inc. since 2024, and Kura Oncology, Inc. since 2021.
Ms. Schafer is also a Director at Onegoal New York since 2019 and Managing Partner at Hyphen Advisors LLC since 2018.
Former roles include Vice Chairman-Equity Capital Markets at Wells Fargo Securities LLC from 2007 to 2018, Independent Director at Idera Pharmaceuticals, Inc. from 2018 to 2022, Independent Director at Five Prime Therapeutics, Inc. from 2019 to 2021, Independent Director at Repare Therapeutics, Inc. from 2019 to 2026, VP-Finance, Business Development & Communications at Lexicon Pharmaceuticals, Inc. from 2003 to 2007, and MD, VP & Head-Equity Capital Markets at J.P.
Morgan & Co., Inc. (Old) from 1986 to 2003.
Education includes undergraduate studies at Boston College and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED 0,03 % | 13/05/2026 | 63 317 ( 0,03 % ) | 7 M $ | 31/05/2026 |
IMMUNOME, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
KURA ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Carol Schafer
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur/Membre du Conseil | 01/04/2020 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 03/06/2021 |
| IMMUNOME, INC. | Directeur/Membre du Conseil | 02/01/2024 |
Hyphen Advisors LLC | Directeur Général | 01/01/2018 |
Onegoal New York
 Onegoal New York Miscellaneous Commercial ServicesCommercial Services Operates social services organization | Directeur/Membre du Conseil | 01/03/2019 |
Anciens postes connus de Carol Schafer
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 28/01/2026 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur/Membre du Conseil | 28/09/2022 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/04/2021 |
Wells Fargo Securities LLC
 Wells Fargo Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/09/2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Carol Schafer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
J.P. Morgan & Co., Inc. (Old)
 J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Operates social services organization | Commercial Services |
Hyphen Advisors LLC |
